跳至主要内容
临床试验/NCT01418859
NCT01418859Unknown不适用

Status and the Application of Topotecan at Post-operation Treatment of Cervical Cancer

Health Science Center of Xi'an Jiaotong University1 个研究点 分布在 1 个国家目标入组 183 人开始时间: 2011年8月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
183
试验地点
1

研究概览

简要总结

The purpose of the research is to evaluate the effect of additional chemotherapy in postoperation therapy of cervical cancer patients with risk factors (big tumor, deep invasion or tumor thrombi in the vascular system).

详细描述

Cervical cancer has a very high morbidity. Many patients need additional therapy after surgery in order to elevate the survival rate and life quality. In this research, we are going to give additional therapy to patients who have big tumor, deep invasion or tumor thrombi in the vascular system after surgery. randomized control method will be used in this research, in order to compare the survival rate and side effects between radiation therapy only, concurrent chemoradiotherapy, and concurrent chemoradiotherapy with additional chemotherapy. 3D-CRT and Topotecan will be used in this research.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • patients who underwent the cervical cancer radical surgery in three months have higt risk factors which including deep stromal invasion,large primary tumour and/or lymphovascular spase invasion;
  • squamous carcinoma;
  • Gynecologic Oncology Group (GOG):0-2.

排除标准

  • negative nodes,surgical margin,and/or parametrium;
  • No serious damage to the liver and kidney function, no hypertension,diabetes and other effects of therapy complications.

研究者

发起方
Health Science Center of Xi'an Jiaotong University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Liu Zi

Profesor

Health Science Center of Xi'an Jiaotong University

研究点 (1)

Loading locations...

相似试验